Home » Topics » Regulatory » Patents

Patents
RSS

Synthelabo describes new series of serotonergic antagonists

Nov. 24, 1998

Antiinflammatory tetrazoles in development at Ono

Nov. 23, 1998

Merck & Co. presents potent and selective sst2 receptor agonists

Nov. 23, 1998

Bayer claims broad-spectrum oxazolidinones

Nov. 23, 1998

New MRI contrast agents with favorable neurotoxicity profile developed at Bracco

Nov. 23, 1998

Osteoclast differentiation inhibitors for arthritis under study at Sumitomo

Nov. 23, 1998

Dual NK1 and NK2 receptor antagonists under study at Sankyo for respiratory disorders, incontinence

Nov. 20, 1998

Antitumor tetramic acid compound produced by Streptomyces

Nov. 20, 1998

Erythromycin derivatives with high activity against sensitive and resistant microorganisms

Nov. 20, 1998

Picornavirus protease inhibitors from Agouron especially useful for rhinovirus infections

Nov. 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 18, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Fosun secures rights to Aribio’s AR-1001 in potential $4.7B deal
BioWorld
Shanghai Fosun Pharmaceutical (Group) Co. Ltd. is paying $60 million up front for an option to secure exclusive rights to Aribio Co. Ltd.’s oral phase III-stage...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...